等待开盘 02-07 09:30:00 美东时间
0.000
0.00%
Onconetix, Inc. 宣布其股东批准了1:85的反向股票分割,以符合纳斯达克的最低股价要求。此次分割将在6月13日生效,流通股数将从4440万股减少至约52万股。此外,公司专注于男性健康和肿瘤学领域的生物技术产品。
2025-06-11 15:30
Onconetix, Inc. received a delisting notice from Nasdaq due to failure to file the 10-Q quarterly report, adding to previous violations of the minimum bid price rule. The company has requested a hearing scheduled for May 27, 2025, and intends to promptly file the required reports to regain compliance.
2025-05-22 20:50
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 2月19日,一向低调的石药突然冲到了舆论中心。 当日,石药集团发布公告:旗下子...
2025-02-24 23:36
U.S. stocks traded higher toward the end of trading, with the Dow Jones index s...
2024-09-13 02:01
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gain...
2024-09-13 00:10
Brookline Capital analyst Kemp Dolliver downgrades Oncternal Therapeutics (NASDAQ:ONCT) from Buy to Hold.
2024-09-12 23:16
U.S. stocks traded mixed this morning, with the Dow Jones index falling more th...
2024-09-12 22:23